Search

everythinglearnresearchcommunity

for

Search:↓

The meeting discussed vitamin D3's role in fighting tuberculosis, potential treatments for skin conditions like psoriasis, and hair follicle regeneration as a possible solution for hair loss.

Dietary lipids affect inflammation and are crucial for normal cell function and immune health.

Taking a probiotic supplement twice a day improved hair growth, skin hydration, and metabolic health in adults at risk of metabolic syndrome.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

IL-1 receptor absence in mice leads to skin cysts and changes in immune response after UVB exposure.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

IL-13 protein is much higher in the skin of atopic dermatitis patients than in healthy skin.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

A new IL6ST gene variant may cause a unique form of hyper-IgE syndrome with skin abscesses and high IgE levels.

Certain genetic variations in IL-16 may increase the risk of alopecia areata.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

CXCL12+ fibroblasts help recruit neutrophils to fight skin infections.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Removing SIX1 in fat cells reduces skin fibrosis.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Cholecystokinin may help reduce skin inflammation in psoriasis.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Systemic sclerosis skin shows varied gene patterns, suggesting potential for personalized treatment.

SPT6 prevents excessive skin inflammation by blocking a feedback loop.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

PCOS is linked to low-grade chronic inflammation.